ChinaCureLinkSep 46 min readAdvancesB-cell lymphoma CAR-T therapy China: BRL-201 for B-Cell Non-Hodgkin Lymphoma — 2026 International Patient Guide
ChinaCureLinkSep 26 min readCasesA 60% Match: How CAR-T and Transplant Saved a Child From Relapsed Leukemia in China
ChinaCureLinkSep 17 min readCasesUnder 10% Odds: How CAR-T Achieved Complete Remission for a 70-Year-Old Lymphoma Patient in China
ChinaCureLinkSep 15 min readCases28 Days: How Dual-Target CAR-T Turned Around a Critical Lymphoma Case for an Egyptian Patient in China
ChinaCureLinkAug 285 min readCasesWhen Insulin and Medication Stopped Working: How a Canadian Diabetes Patient Found Stem Cell Therapy in China - A Case Study
ChinaCureLinkAug 276 min readBlogUmbilical Cord-Derived Mesenchymal Stem Cell Therapy for Type 2 Diabetes in China: 2026 International Patient Guide
ChinaCureLinkAug 2111 min readBlogBest Lymphoma Hospitals in China: Top Centers, CAR-T Access & 2026 Costs
ChinaCureLinkAug 2112 min readBlog5 Best Lymphoma Hospitals in Asia: Top Centers, CAR-T Access & 2026 Cost Comparison
ChinaCureLinkAug 209 min readBlogBest Leukemia Hospitals in China (2026): Clinical Guide for International Patients
ChinaCureLinkAug 2012 min readBlogBest Leukemia Hospitals in the World: A 2026 Guide to Top Cancer Centers and CAR-T Access
ChinaCureLinkAug 198 min readDiseaseBest Leukemia Hospitals in Asia: A 2026 Patient's Guide to World-Class Treatment, CAR-T Access & Cost Savings
ChinaCureLinkAug 59 min readCasesCase Study: Twice-Relapsed Lymphoma, One CAR-T Infusion, and a 60-Day Watch That Ended in Remission
ChinaCureLinkJul 297 min readCasesCase Study: Wheelchair-Bound With Bone-Wide Lymphoma, She Was Cancer-Free on PET/CT One Month After CAR-T Therapy at a Shanghai Hospital
ChinaCureLinkJul 298 min readCasesPediatric CAR-T Case Study: How a Chinese Boy Beat Leukemia With CAR-T Therapy — and Stayed Cancer-Free for 3+ Years Without a Matched Donor
ChinaCureLinkJul 18 min readCasesCAR-T Treatment in China for Rare Intestinal T-Cell Lymphoma (MEITL): A Case Study
ChinaCureLinkJun 249 min readCasesRelapsed T-Cell Leukemia, CD7 CAR-T Therapy, and a Second Chance in China
ChinaCureLinkJun 2312 min readBlogIs China Effective at Treating Leukemia? Domestic CAR-T Reaches Up to 92% Response in Refractory B-ALL
ChinaCureLinkJun 2312 min readBlog2026 Breakthrough: China's CAR-T for Advanced Lymphoma Reaches 79%+ Response Rate
ChinaCureLinkJun 227 min readBlogIs China's Stem Cell Therapy for Type 2 Diabetes Effective? How Regenerated Islet Cells May Restore Insulin Production
ChinaCureLinkJun 2210 min readCasesDual-Target CAR-T Cell Therapy for Refractory and Relapsed Burkitt Lymphoma: A Five-Year Survival Case Study in China
